Evaluation of miR-216a and miR-217 as potential biomarkers of acute pancreatic injury in rats and mice

Biomarkers

Volumn 19, Issue 6, 2014, Pages 517-529

  Goodwin, David ^a   Rosenzweig, Barry ^a   Zhang, Jun ^a   Xu, Lin ^a   Stewart, Sharron ^a   Thompson, Karol ^a   Rouse, Rodney ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Caerulein; MicroRNA; Pancreas; Pancreatitis

Indexed keywords

AMYLASE; ARGININE; CERULETIDE; MICRORNA; MICRORNA 216A; MICRORNA 217; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN-217 MICRORNA, MOUSE; MIRN216 MICRORNA, MOUSE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PANCREAS DUCT LIGATION; PANCREAS INJURY; QUANTITATIVE ANALYSIS; RAT; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; PANCREAS; PANCREATITIS; PATHOLOGY; SPRAGUE DAWLEY RAT;

AMYLASES; ANIMALS; ARGININE; BIOLOGICAL MARKERS; CERULETIDE; MALE; MICE, INBRED C57BL; MICRORNAS; PANCREAS; PANCREATITIS; RATS, SPRAGUE-DAWLEY; ROC CURVE;

EID: 84906331490     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.944217     Document Type: Article

References (44)

1. Amodio A, Manfredi R, Katsotourchi AM, et al. (2012). Prospective evaluation of subjects with chronic asymptomatic pancreatic hyperenzymemia. Am J Gastroenterol 107:1089-95.
2. Baskerville S, Bartel DP. (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241-7.
3. Boland CL, Degeeter M, Nuzum DS, Tzefos M. (2013). Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors. Ann Pharmacother 47:490-505.
4. Brackett KA, Crocket A, Joffe SN. (1983). Ultrastructure of early development of acute pancreatitis in the rat. Dig Dis Sci 28:74-84.
5. Bushati N, Cohen SM. (2007). microRNA functions. Annu Rev Cell Dev Biol 23:175-205.
6. Chan YC, Leung PS. (2007). Acute pancreatitis: animal models and recent advances in basic research. Pancreas 34:1-14.
7. Clavien PA, Robert J, Meyer P, et al. (1989). Acute pancreatitis and normoamylasemia. Not an uncommon combination. Ann Surg 210: 614-20.
8. Dawra RK, Saluja AK. (2012). L-arginine-induced experimental acute pancreatitis. Pancreapedia: Exocrine Pancreas Knowledge Base, DOI: 10.3998/panc.2012.6.
9. dEmden MC, Wong L, Harris OD. (1984). Serum amylase, isoamylase and lipase in acute alcoholism. Aust N Z J Med 14:819-21.
10. Denker PS, Dimarco PE. (2006). Exenatide (exendin-4)-induced pancreatitis: a case report. Diabetes Care 29:471.
11. Dylewski ML, Prelack K, Keaney T, Sheridan RL. (2010). Asymptomatic hyperamylasemia and hyperlipasemia in pediatric patients with toxic epidermal necrolysis. J Burn Care Res 31:292-6.
12. Endo K, Weng H, Kito N, et al. (2013). MiR-216a and miR-216b as markers for acute phased pancreatic injury. Biomed Res 34:179-88.
13. Fabian MR, Sonenberg N, Filipowicz W. (2010). Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-79.
14. Gaisano HY, Gorelick FS. (2009). New insights into the mechanisms of pancreatitis. Gastroenterology 136:2040-4.
15. Hermann RE, Davis JH. (1960). The role of incomplete pancreatic duct obstruction in the etiology of pancreatitis. Surg Forum 10:230-2.
16. Hindson CM, Chevillet JR, Briggs HA, et al. (2013). Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Meth 10:1003-5.
17. Iyer SN, Drake III AJ, West RL, et al. (2012). Case report of acute necrotizing pancreatitis associated with combination treatment of sitagliptin and exenatide. Endocr Pract 18:e10-13.
18. Ji X, Takahashi R, Hiura Y, et al. (2009). Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55:1944-9.
19. Kolars J, Ellis C, Levitt M. (1984). Comparison of serum amylase pancreatic isoamylase and lipase in patients with hyperamylasemia. Dig Dis Sci 29:289-93.
20. Kong XY, Du YQ, Li L, et al. (2010). Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis. World J Gastroenterol 16:4599-604.
21. Laterza OF, Lim L, Garrett-Engele PW, et al. (2009). Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55:1977-83.
22. Liang Y, Ridzon D, Wong L, Chen C. (2007). Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8:166.
23. Matull W, Pereira S, ODonohue J. (2006). Biochemical markers of acute pancreatitis. J Clin Pathol 59:340-4.
24. Neoptolemos JP, Rararty M, Finch M. (1998). Acute pancreatitis: the substantial human and financial costs. Gut 42:886-91.
25. Orebaugh S. (1994). Normal amylase levels in the presentation of acute pancreatitis. Am J Emerg Med 12:21-4.
26. Rouse R, Rosenzweig BA, Thompson KL. (2014). Circulating microRNAs as biomarkers of drug-induced pancreatitis. In: Sahu S, ed. microRNAs in toxicology and medicine. New York: John Wiley &Sons Ltd, 425-36.
27. Shen J, Wan R, Hu G, et al. (2012). Involvement of thrombopoietin in acinar cell necrosis in L-arginine-induced acute pancreatitis in mice. Cytokine 60:294-301.
28. Singh S, Chang HY, Richards TM, et al. (2013). Glucagonlike peptide 1- based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med 25:1-6.
29. Smotkin J, Tenner S. (2002). Laboratory diagnostic tests in acute pancreatitis. J Clin Gastroenterol 34:459-62.
30. Starkey Lewis PJ, Dear J, Platt V, et al. (2011). Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54:1767-76.
31. Su KH, Cuthbertson C, Christophi C. (2006). Review of experimental animal models of acute pancreatitis. HPB (Oxford) 8: 264-86.
32. Szafranska AE, Davison TS, John J, et al. (2007). MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26:4442-52.
33. Tani S, Itoh H, Okabayashi Y, et al. (1990). New model of acute necrotizing pancreatitis induced by excessive doses of arginine in rats. Dig Dis Sci 35:367-74.
34. Tenner S. (2010). Drug-induced acute pancretitis: underdiagnosis and overdiagnosis. Dig Dis Sci 55:2706-08.
35. Toskes PP. (1990). Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 19:783-91.
36. Treacy J, Williams A, Bais R, et al. (2008). Evaluation of amylase and lipase in the diagnosis of acute pancreatitis. ANZ J Surg 71: 577-82.
37. Trivedi C, Pitchumoni C. (2005). Drug-induced pancreatitis: an update. J Clin Gastroenterol 39:709-16.
38. Usborne AL, Smith AT, Engle SK, et al. (2014). Biomarkers of exocrine pancreatic injury in 2 rat acute pancreatitis models. Toxicol Pathol 42: 195-203.
39. Vissers R, Abu-Laban R, McHugh D. (1999). Amylase and lipase in the emergency department evaluation of acute pancreatitis. J Emerg Med 17:1027-37.
40. Wang K, Zhang S, Marzolf B, et al. (2009). Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106:4402-7.
41. Watanabe O, Baccino FM, Steer ML, Meldolesi J. (1984). Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol 246:G457-67.
42. Weber JA, Baxter DH, Zhang S, et al. (2010). The microRNA spectrum in 12 body fluids. Clin Chem 56:1733-41.
43. Yoshinaga K, Washizuka M, Segawa Y. (2000). Fasting exacerbates acute pancreatitis by occlusion of the common bile duct in rats. Jpn J Pharmacol 84:455-61.
44. Zhang J, Rouse R. (2014). Histopathology and pathogenesis of caerulein-, duct ligation-, and arginine-induced acute pancreatitis in Sprague-Dawley rats and C57BL6 mice. Histol Histopathol 29:1135-52.